teladoc glp-1 receptor agonists weight management diabetes treatments Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies GLP-1 Drug Savings: A Complete

[DOI] [PMC free article] [PubMed] [Google Scholar] 40

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management and now widely prescribed for chronic weight management

Not vague advice

When manufacturing supplements for these consumers, capsules can offer distinct advantages such as: With the rise of GLP-1 agonist usage, there is high potential for supplement manufacturers to create products that specifically meet this growing consumer groups needs

Hauge-Evans et al., 2009)

It should deliver meaningful amounts of the nutrients women are most likely to need, in forms the body can actually use